Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00284089
What this trial is testing

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Novartis 88
Testing effectiveness (Phase 2)Study completedNCT03038880
What this trial is testing

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascularization, ChoroidalMacular Degeneration, Age-Related
Hoffmann-La Roche 76
Testing effectiveness (Phase 2)UnknownNCT02599064
What this trial is testing

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

Who this might be right for
Age-related Macular DegenerationSubfoveal Choroidal NeovascularizationSubretinal Scarring+1 more
RXi Pharmaceuticals, Corp. 9
Testing effectiveness (Phase 2)Looking for participantsNCT07630649
What this trial is testing

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Adverum Biotechnologies, Inc. 15
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Post-approval studies (Phase 4)Study completedNCT01831947
What this trial is testing

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

Who this might be right for
Macular Degeneration
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Testing effectiveness (Phase 2)Study completedNCT01037348
What this trial is testing

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

Who this might be right for
Choroidal Neovascularisation
Novartis 65
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT01810042
What this trial is testing

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Pusan National University Hospital 49
Not applicableUnknownNCT04707027
What this trial is testing

Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

Who this might be right for
Polypoidal Choroidal Vasculopathy
Chiang Mai University 80
Testing effectiveness (Phase 2)Study completedNCT02121353
What this trial is testing

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration (AMD)
Pfenex, Inc 25
Testing effectiveness (Phase 2)Ended earlyNCT00395057
What this trial is testing

A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration

Who this might be right for
Choroid NeovascularizationAge-Related Macular Degeneration
Allergan 138
Testing effectiveness (Phase 2)Study completedNCT04290195
What this trial is testing

Use of Ziv Aflibercept in Different Retinal Diseases

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Amin El Sayed Nawar 55
Post-approval studies (Phase 4)Looking for participantsNCT06709339
What this trial is testing

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image 120
Testing effectiveness (Phase 2)WithdrawnNCT01015495
What this trial is testing

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Who this might be right for
Angioid Streaks
University of Illinois at Chicago
Post-approval studies (Phase 4)Study completedNCT02495181
What this trial is testing

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image 50
Large-scale testing (Phase 3)Study completedNCT02034006
What this trial is testing

The Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

Who this might be right for
Choroidal Neovascularization Secondary to Pathologic Myopia
Novartis Pharmaceuticals 200
Not applicableLooking for participantsNCT02669953
What this trial is testing

Aflibercept in Recurrent or Persistent CNV

Who this might be right for
Age Related Macular DegenerationIntravitreal InjectionsDiabetic Macular Edema
Medical University of Vienna 80
Not applicableStudy completedNCT01846351
What this trial is testing

Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

Who this might be right for
Epiretinal MembraneAge Related Macular Degeneration
New England Retina Associates 16
Next Page